Finance

Lists
Why is MOLBIO down 2.06%?
Dive Deeper
MOLBIO:NSE
Molbio Diagnostics Limited
₹1,495.00
-2.06%
(-31.40) 1D
Nov 20, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MOLBIO...
Open
₹1,549.80
High
₹1,580.00
Low
₹1,483.10
Mkt. cap
172.28B
Avg. vol.
1.11M
Volume
700.86K
52-wk high
₹1,686.80
52-wk low
₹926.35
No. of employees
1K
Open
₹1,549.80
High
₹1,580.00
Low
₹1,483.10
Mkt. cap
172.28B
Avg. vol.
1.11M
Volume
700.86K
52-wk high
₹1,686.80
52-wk low
₹926.35
No. of employees
1K
News stories
From web sources and news partners
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis. The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries. In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited
CEO-
Employees1.22K
Founded2000
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Jun 2026
Sep 2026
Revenue
997.08M
5.80B
4.08B
2.59B
Cost of goods sold
351.74M
2.22B
1.50B
993.97M
Cost of revenue
351.74M
2.22B
1.50B
993.97M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
281.78M
338.82M
459.20M
377.97M
Operating expense
921.10M
2.03B
1.75B
1.39B
Total operating expenses
1.27B
4.26B
3.25B
2.38B
Operating income
-275.76M
1.54B
835.09M
205.89M
Other non operating income
7.60M
10.92M
31.00M
57.74M
EBT including unusual items
-312.78M
1.48B
759.09M
175.05M
EBT excluding unusual items
-312.78M
1.48B
759.09M
175.05M
Income tax expense
-73.34M
408.97M
231.65M
98.04M
Effective tax rate
23.45%
27.68%
30.52%
56.01%
Other operating expenses
516.13M
1.56B
1.12B
778.79M
Net income
-237.14M
1.10B
587.47M
151.22M
Net profit margin
-23.78%
18.92%
14.39%
5.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-36.13M
-69.77M
-106.99M
-88.58M
Net interest expenses
-36.13M
-69.77M
-106.99M
-88.58M
Depreciation and amortization charges
123.19M
138.12M
170.75M
233.58M
EBITDA
-184.42M
1.64B
966.77M
408.06M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps